Els Janssens

Els Janssens is a Senior Counsel in the Brussels office, advising pharmaceutical, biotechnology, medical device and digital health companies on regulatory, market access, compliance and public affairs matters across Europe and the Middle East.

Prior to private practice, Els served as Senior Regulatory Legal Counsel at Johnson & Johnson, where she supported the company's global safety organisation and advised on regulatory issues relating to medicinal products in the EU.

Els also worked as Legal Adviser at the European Medicines Agency (EMA), advising the Agency's management, scientific committees and the European Commission on a broad range of EU pharmaceutical law issues, including scientific advice, marketing authorisation procedures, pharmacovigilance, inspections, post-market procedures and regulatory enforcement matters.

From 2014 to 2019, Els was based in Abu Dhabi, where she advised multinational pharmaceutical and medical device companies, healthcare providers and industry associations on healthcare regulation, market access, compliance and commercial matters across the Gulf region. She continues to be recognised for her extensive experience in UAE and wider GCC healthcare regulation.

Els regularly supports clients on complex regulatory strategies, clinical trials, EU pharmaceutical legislation, Health Technology Assessment (HTA), pricing and reimbursement, market entry, compliance programmes, transactions and regulatory due diligence.